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This cohort prospective intervention study was initiated to investigate the effectiveness of
mucolytic nasal wash on postoperative healing after endoscopic nasal surgery (ENS).
A total of 60 patients of both sexes, above 21 years, underwent ENS, who were randomly
distributed into two groups according to inclusion and exclusion criteria, with 30 patients
each. Postoperative hypertonic saline nasal irrigation was used for group A, and in addition
of N‑acetylcysteine (NAC) in group B. Measurement of outcome was done using modified
Symptom based Modified Sino‑Nasal‑Outcome Test score‑22 and Lund–Kennedy endoscopic
score.

Results

We noticed that nasal irrigation with combined hypertonic saline with NAC is effective in
reducing postoperative symptoms scores and endoscopic scores for patients following ENS
or functional endoscopic sinus surgery.

Conclusion

NAC combined hypertonic saline irrigation had significant better results than standard hypertonic
saline nasal irrigation only following endoscopic sinus surgery, significantly improving patient’s
quality of life.
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Background
For many years, ENT surgeons all over the world used
postoperative nasal irrigation after nasal surgeries, and
it became one of the standard postoperative procedures.
After introducing endoscopic nasal surgery (ENS), the
need for effective irrigation that removes debris, crusts,
liquefies mucus, and washes organisms as well as causes
changes in their growth environment became more
mandatory for effective healing and improving quality
of life (QOL) of patients [1].
Isotonic saline nasal irrigation has been considered as
one of the oldest methods after nasal surgeries as it is an
easy used and cheap preparation. Its use was restricted,
as it inhibits mucociliary beating and was less effective
in reducing tissue edema and crust removal [2].
Hypertonic nasal washes were found to produce
an obvious statistically significant beneficial effect
resulting in the relief of discomfort caused by crusting
and accumulation of abnormal nasal discharge
after functional endoscopic sinus surgery. It was
recommended for nasal douching after corrective
nasal septal surgery (septoplasty), functional
endoscopic sinus surgery, and surgical removal of nasal
polyps (polypectomy). The use of hypertonic wash
facilitates maintenance of normal patency of the nasal

cavities, reduces tissue edema, improves mucociliary
mechanisms, reduce biofilm formation, and speeds up
healing of iatrogenic injuries of the mucous membrane
of the nose [3].
The only disadvantage of hypertonic solutions is mild
nasal irritation and burning sensation at the start of
use; usually most of the patients rapidly accommodates
with this [4].
Although there is a wealth of literature available, the
establishment of treatment protocol can be difficult
because of the great variability in recommended
composition (normal and hypertonic saline, sea water,
with or without additives), and the technique of
irrigation, its pressure, frequency, and volume.
Adding mucolytics seems to be an elegant idea
which logically goes with all the purposes needed for
complete effective postoperative nasal care and rapid
healing after ENS.
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Hypertonic saline (2.3%) was the most recommended
following ENS, with very few papers using mucolytics
in addition. N‑acetylcysteine (NAC) could be
considered a mucolytic drug of choice owing to its
availability, multiple forms, low price, easy use, and
high safety profile [5,6].
This cohort prospective comparative intervention study
was initiated to investigate the effectiveness and added
value of mucolytics combined hypertonic saline nasal
wash versus hypertonic saline alone following ENS.

Patients and methods
This study was conducted in ENT Department,
Dallah Hospital, KSA, and was designed to include
60 adult patients undergoing ENS during the period
between March 2017 and March 2019. It included all
patients who agreed to join the study and signed a clear
informed consent, after providing them with complete
information about protocol, benefits, and risks. The
study was approved by the hospital medical ethical
committee.
Patients
fulfilling
inclusion
and
exclusion
criteria (Table 1) were divided randomly in a parallel
assignment into two groups, with 30 patients each,
using a computer software program, and the box
containing the bottles was the same, regardless which
one was used.
Group A included 30 who had irrigation with
hypertonic saline 2.3%, with 20 ml for each nostril three

times daily (hypertonic saline poured and delivered
using commercially manufactured bottles) (Fig 1).
Group B included 30 patients who had irrigation
with hypertonic saline and mucolytics (NAC powder
200 mg dissolved in 200 ml hypertonic saline used in
other group), with 20 ml for each nostril three times
daily (hypertonic saline poured and delivered using
commercially manufactured bottles).
All medication was used for 6 weeks postoperatively,
and patients were instructed regarding the correct
irrigation technique before discharge from the hospital
and remained in each clinic follow‑up.
Outcome assessment was subjectively done using
Symptom based Modified Sino‑Nasal‑Outcome Test
scores (SNOT‑7). We selected seven main symptoms,
as they were most reliable, creditable, clear, and
consistent with the subject of this research (Table 2).
For objective outcome, we found sign‑based
endoscopic scoring system by Lund–Kennedy the
most simple and informative without a lot of gray
zones (Table 3).
Statistical analysis of the collected data was done
by using SPSS, version 17 (Chicago, IL, USA).
Quantitative data were presented as mean and SD and
were analyzed by using one‑way analysis of variance
test. Qualitative data were presented as numbers
and percentages and were analyzed by using χ2 test
and Fisher extract test. P value less than 0.05 was
considered significant, whereas P value less than 0.01
was considered highly significant.

Table 1 Inclusion and exclusion criteria
Inclusion criteria

Exclusion criteria

Age over 21and below 60 years

Allergy to N‑acetylcysteine
Inflammatory nasal pathology (Wegener, sarcoidosis, etc.)
Systemic nasal affection (cystic fibrosis, Kartagener, etc.)

Patients undergoing ENS for chronic sinusitis, nasal polyposis,
septoplasty, and turbinectomy (either separately or combined)

Nasal tumor surgery or proved postoperatively
Previous radiotherapy to the head and neck
Revision surgery
ENS, endoscopic nasal surgery.
Table 2 Symptom based Modified Sino‑Nasal‑Outcome Test‑7) Questionnaire [7]

Need to blow nose
Nasal obstruction
Loss of smell or taste
Postnasal discharge
Thick nasal discharge
Facial pain
Sleep‑related difficulties
Total score

No
problem

Very mild
problem

Mild or slight
problem

Moderate
problem

Sever
problem

Problem as bad
as it can be

0
0
0
0
0
0
0

1
1
1
1
1
1
1

2
2
2
2
2
2
2

3
3
3
3
3
3
3

4
4
4
4
4
4
4

5
5
5
5
5
5
5

Important
notes
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Results
Although during this study we did parallel
randomization, the results regarding age and sex
showed no significant statistical difference between
groups A and B (Tables 4 and 5).
The first main arm of postoperative assessment in this
study was the subjective symptomatic improvement or
complications based on our modification of SNOT‑test.
Seven main symptoms that were most relevant to
this study were as much as possible effectively and
accurately obtained and subjected to relevant statistical
analysis.
We found significant statistical difference favoring
group B (added mucolytic) in postoperative subjective
improvement. Group B showed more significant
improvement with less need to blow the nose, less
postnasal discharge both in amount and thickness,
more open nose, less facial pain, more good smelling
ability, and more improvement regarding the total
score (in the main three follow‑up timings at 15, 30,
and 45 days postoperatively).
Regarding the snoring, both groups showed no
significant difference (Table 6).
The second arm was the objective postoperative
endoscopic assessment using Lund–Kennedy scoring,
where group B (added mucolytics) showed more
significant improvement including less nasal mucosal
edema with more patent nose, less accumulated
discharge, and less crusting, with more better total score.
In both groups until the end of follow‑up period for at
least 6 months, no patient was found to have permanent
adhesions or nasal polyp recurrence (Table 7 and
Figs. 2–5).
Figure 1
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Discussion
Postoperative follow‑up for endoscopic sinus surgery was
a very important issue and also considered as important
as surgery. This was done mainly by suction and
debridement during endoscopic examination, combined
with irrigation of the nose and paranasal sinuses [9].
Suction and irrigation remove any blood clot, crust, and
fibrin, thereby preventing adhesion postoperatively.
Hypertonic saline now provides more efficacy and
safety in postoperative nasal irrigation than normal
saline, with less defaults like nasal irritation and
burning sensation [10–13].
The mucolytic effect of NAC is explained by its
thiol (sulfhydryl) groups ‘hydrolyze disulfide bonds
of mucins and other proteins.’ Acetylcysteine is also
an antioxidant and reduces oxidative stress, had
rapid healing neuropsychotropic effects, and lastly,
acetylcysteine also possesses some anti‑inflammatory
effects possibly via inhibiting NF‑KB through redox
activation of the nuclear factor kappa kinases, thereby
modulating cytokine synthesis in addition to inhibition
of biofilm formation, which contributes to chronicity
of infection [14,15].
Our results were independent of demographic variables.
We used strict inclusion and exclusion criteria, and all
operations were performed by the same technique to
prevent the introduction of confounding factors and to
ensure standardization, which decrease bias.
During preparation for this study, we excluded patients
with granulomas, tumors, systemic nasal affection,
Table 3 Sign‑based scoring (Lund‑Kennedy endoscopic
score): it was applied to each side of the nose using
endoscopic examination [8]
Grade 0

Grade 1

Grade 2

Edema
Discharge
Crusts
Adhesion

None
None
None
None

Mild
Clear/thin
Middle meatus (MM) only
MM only

Severe
Thick/purulent
Beyond MM
Beyond MM

Polyps

None

MM only

Beyond MM

Table 4 Comparison between the study groups regarding age
Group

Mean±SD

t

P

Significance

A

35.5±1.75

−1.52

0.133

Non

B

36.2±1.81

Table 5 Comparison between the study groups regarding sex

Commercially used bottles for nasal irrigation.

Sex

χ2 test

Female

Male

Group
A

19

11

B

21

9

P

Significance

0.300

Non
0.584

Group B

2.48±0.54

3.67±1.1
2.2±0.6
1.07±0.25
2.9±0.70
3.00±0.52
2.57±0.33
2.35±0.3

t

8.97

2.79
22.9
31.25
9.46
5.70
8.2
1.411

P

0.001<0.01

0.008<0.01
0.001<0.01
0.001<0.01
0.001<0.01
0.001<0.01
0.001<0.01
0.157>0.05

Group A

2.11±0.55

3.68±1.5
2.4±0.5
2.03±0.43
2.9±0.34
2.03±0.51
1.13±0.31
0.57±0.25
0.92±0.45

2.81±1.8
1.07±0.6
0.30±0.48
0.53±0.22
0.70±0.63
0.63±0.43
0.49±0.23

Group B

9.17

2.03
9.33
17.48
32.05
8.99
6.15
1.15

t

30 up to 45 days
P

0.001<0.01

0.047<0.05
0.001<0.01
0.001<0.01
0.001<0.01
0.001<0.01
0.001<0.01
0.108>0.05
0.68±0.15

1.4±1.3
0.97±0.7
0.97±0.32
0.73±0.67
0.30±0.41
0.23±0.20
0.13±0.15

Group A

0.22±0.13

0.47±1.7
0.10±0.9
0.67±0.23
0.10±0.54
0.033±0.38
0.10±0.25
0.12±0.59

Group B

t

12.69

2.38
4.18
4.17
4.01
2.62
2.22
0.87

After 45 days
P

0.001<0.05

0.021<0.05
0.001<0.01
0.001<0.01
0.001<0.01
0.011<0.05
0.030<0.05
0.286>0.05

Total score

Nasal mucosa edema
Nasal discharge.
Crusts
Adhesion
Polyps

1.913±0.356

1.90±0.39
1.87±0.35
1.97±0.33
0
0

Group A

1.109±0.306

1.36±0.30
1.43±0.32
1.43±0.3
0
0

Group B

After 15 days

9.38

6.01
5.08
6.63

t

0.001<0.01

0.001<0.01
0.001<0.01
0.001<0.01
NA
NA

P

1.999±0.266

1.3±0.29
1.067±0.27
1.23±0.24
0
0

Group A

0.334±0.220

0.367±0.22
0.267±0.21
0.37±0.23
0
0

Group B

t

13.37

14.02
12.81
14.17

30 up to 45 days

0.0001<0.01

0.001<0.01
0.001<0.01
0.001<0.01
NA
NA

P

0.343±0.263

0.33±0.54
0.30±0.14
0.40±0.11
0
0

Group A

0.055±0.140

0.067±0.15
0.067±0.15
0.033±0.12
0
0

Group B

t

5.29

6.57
6.22
12.35

After 45 days

0.001<0.01

0.001<0.01
0.001<0.01
0.000<0.01
NA
NA

P

Table 7 Collective comparative postoperative objective scoring results using Lund‑Kennedy endoscopic scoring system with its statistical analysis and P significance value in the main
three postoperative assessment visits

3.79±0.59

Total score

Group A

4.73±1.7
4.07±0.2
3.07±0.22
4.87±0.90
3.73±0.47
3.37±0.42
2.57±0.22

Need to blow the nose
Nose block
Postnasal discharge
Thick discharge
Facial pain
Smell
Sleep diff.

After 15 days

Table 6 Collective comparative postoperative subjective scoring results using modified Symptom based Modified Sino‑Nasal‑Outcome Test score‑7 test with its statistical analysis and P
significance value in the main three postoperative assessment visits
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Figure 2

(a and b) Early postoperative endoscopic view with splints in both groups.

Figure 4

(a and b) 30‑day postoperative endoscopic view in both groups.
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Figure 3

(a and b) 15‑day postoperative endoscopic view in both groups.

Figure 5

(a and b) 45‑day postoperative endoscopic view in both groups.

and revision nasal surgery. These disorders need wide
surgical field and extensive resection, with subsequent
severe crustations, thereby delaying healing, with
consequent bias of results.

is important in studying patient’s QOL outcomes and
subjective perception of improvement. We selected even
symptoms, as they were most reliable, creditable, clear,
and consistent with the subject of this research.

Most of literature agreed to use hypertonic saline (2.3%
NaCl) as a standard irrigation concentration, with 20
ml at least for each nostril. We used the same standard
three times daily procedure, which we think was
sufficient for effective irrigation and cleaning of nasal
mucosa.

Moreover, we found that Lund–Kennedy endoscopic
sign‑based scale was most simple, informative, rapid
to do, and none conflicting more details which will not
add to outcome.

Our colleagues in biochemistry advised NAC
concentration not exceeding 200 mg/200 ml hypertonic
saline, as this was proved effective in mucolytic function
and did not alter the tonicity of the solution.
We started first follow‑up assessment after 2 weeks
from surgery when all packs and splints were removed
to avoid their conflict over the results, and then
ended in 6 weeks, where healing was stabilized and
crustations stopped, and results from this time onward
are dependent on many factors other than irrigation.
For standardization purpose, we used the same
commercially available bottle for all patients of both
groups, to ensure same irrigation pattern and volume.
In literature, nasal symptoms were best assessed with
SNOT‑22. It was the most used questionnaire, with good
consistency, reliability, and reproducibility in literature. It

In this study, effective randomization was done, with
no significant differences between the two groups
regarding age and sex.
Most of studies about postoperative nasal irrigation
such as Talbot et al.[16] and Keojampa et al.[4] agreed
that the use of hypertonic saline for nasal irrigation
has better outcome of mucociliary clearance by
decrease in edema and inflammation and softening of
the secretion owing to its alkaline nature. Moreover,
hypertonic saline was found to increase Ca release
from the intracellular stores stimulating the ciliary beat
by regulating the use of adenosine triphosphate [17].
This also agreed with Kumar et al. [18]. Nasal irrigation
after endoscopic sinus surgery is effective in symptom
resolution and normalization of mucosa appearance.
Hypertonic saline irrigation was significantly more
effective as compared with isotonic saline.
Moreover, Kurtaran et al. [19], reported hypertonic sea
water, especially 2.3%, is the best solution for relieving
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nasal crusting, dryness, and obstruction following
septoplasty and concha radiofrequency.
Robinson et al.[20] and Homer et al.[21] reported that
the use of hypertonic saline has steadily increased because
it reduces edema and increases mucociliary clearance.
The use of hypertonic saline with NAC had more
significant effect in improving postoperative symptoms
like need to blow the nose, nasal blockage, postnasal
discharge, thick nasal discharge, decrease sense of
smell, and facial pain. All were highly improved with
addition of NAC to the hypertonic solution, with a
great effect on patient’s QOL.
Only the sleep‑related symptoms were found not
significant between the two groups. This could be
related to its multifactorial predisposition.
The total score of modified SNOT‑7 was significantly
improved in the NAC group. This could be attributed
to decrease in edema by its anti‑inflammatory effect
and decrease the viscosity of secretion and increase the
mucociliary clearance.
In this study, nasal mucosal edema, discharge, and
crusts all showed more significant improvement with
the use of hypertonic saline with mucolytic NAC than
hypertonic nasal saline irrigation alone. Adhesion and
recurrent polyposis in the first 6 weeks fortunately did
not happen in both groups.
NAC decreases inflammation and goblet cell loss.
Therefore, NAC has potential beneficial effects on the
wound healing of nasal mucosa [22].
Moreover, (Hubert) Low et al. [23], reported hypertonic
saline solution resulted in the quicker resolution of
polypoidal mucosa. This finding is consistent with
other studies where nasal irrigation with hypertonic
solution with NAC resulted in improved radiological
appearances of the sinuses among patients with chronic
rhinosinusitis.
The use of hypertonic saline with mucolytics is
considered a safe method for postoperative nasal
irrigation with no adverse effects. Occasionally patients
felt some discomfort, but it is a well‑tolerated therapy,
comfortable, convenient, available, easy use, low cost,
safe, and effective. We did not perceive any risks with
this combination.

Conclusion
From this study, the use of combination of hypertonic
saline and mucolytics is effective to improve QOL

and reducing postoperative symptoms as assessed by
modified SNTO‑7 score and reducing postoperative
signs as assessed by Lund–Kennedy endoscopic score.
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